Literature DB >> 19804826

Protein kinase D stabilizes aldosterone-induced ERK1/2 MAP kinase activation in M1 renal cortical collecting duct cells to promote cell proliferation.

Victoria McEneaney1, Ruth Dooley, Brian J Harvey, Warren Thomas.   

Abstract

Aldosterone elicits transcriptional responses in target tissues and also rapidly stimulates the activation of protein kinase signalling cascades independently of de novo protein synthesis. Here we investigated aldosterone-induced cell proliferation and extra-cellular regulated kinase 1 and 2 (ERK1/2) mitogen activated protein (MAP) kinase signalling in the M1 cortical collecting duct cell line (M1-CCD). Aldosterone promoted the proliferative growth of M1-CCD cells, an effect that was protein kinase D1 (PKD1), PKCdelta and ERK1/2-dependent. Aldosterone induced the rapid activation of ERK1/2 with peaks of activation at 2 and 10 to 30 min after hormone treatment followed by sustained activation lasting beyond 120 min. M1-CCD cells suppressed in PKD1 expression exhibited only the early, transient peaks in ERK1/2 activation without the sustained phase. Aldosterone stimulated the physical association of PKD1 with ERK1/2 within 2 min of treatment. The mineralocorticoid receptor (MR) antagonist RU28318 inhibited the early and late phases of aldosterone-induced ERK1/2 activation, and also aldosterone-induced proliferative cell growth. Aldosterone induced the sub-cellular redistribution of ERK1/2 to the nuclei at 2 min and to cytoplasmic sites, proximal to the nuclei after 30 min. This sub-cellular distribution of ERK1/2 was inhibited in cells suppressed in the expression of PKD1. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19804826     DOI: 10.1016/j.jsbmb.2009.09.014

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  5 in total

1.  PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-κB- and HDAC1-mediated expression and activation of uPA.

Authors:  Zhipeng Zou; Fangyin Zeng; Wanfu Xu; Chunxia Wang; Zhiyong Ke; Q Jane Wang; Fan Deng
Journal:  J Cell Sci       Date:  2012-07-13       Impact factor: 5.285

2.  Protein kinase D2 contributes to TNF-α-induced epithelial mesenchymal transition and invasion via the PI3K/GSK-3β/β-catenin pathway in hepatocellular carcinoma.

Authors:  Yun Zhu; Yang Cheng; YaBin Guo; JinZhang Chen; FengSheng Chen; RongCheng Luo; AiMin Li
Journal:  Oncotarget       Date:  2016-02-02

3.  Protein kinase D3 modulates MMP1 and MMP13 expression in human chondrocytes.

Authors:  Jonathan Baker; Adrian M D Falconer; David J Wilkinson; G Nicholas Europe-Finner; Gary J Litherland; Andrew D Rowan
Journal:  PLoS One       Date:  2018-04-13       Impact factor: 3.240

Review 4.  Interfering with mineralocorticoid receptor activation: the past, present, and future.

Authors:  Anne M Dorrance
Journal:  F1000Prime Rep       Date:  2014-08-01

Review 5.  Multifaceted Functions of Protein Kinase D in Pathological Processes and Human Diseases.

Authors:  Xuejing Zhang; Jaclyn Connelly; Yapeng Chao; Qiming Jane Wang
Journal:  Biomolecules       Date:  2021-03-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.